<HashMap><database>ecrin-mdr-crc</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>0</viewCount><searchCount>0</searchCount></scores><additional><omics_type>Clinical</omics_type><study_start_year>2022</study_start_year><condition>colorectal cancer</condition><disease>Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/37392</full_dataset_link><location>China</location><study_start_month>2</study_start_month><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status><citation_count>0</citation_count></additional><is_claimable>false</is_claimable><name>Quantitative fecal immunochemical test guided colonoscopy on the detection rate of colorectal lesions: a multicenter randomized controlled trial</name><description>Interventions: Experimental group:Guided by FIT;Control group:None
Primary outcome(s): advanced neoplasm detection rate
Study Design: N of 1 Trial</description><dates><creation>2022-02-15</creation></dates><accession>37392</accession><cross_references><Chinese Clinical Trial Register>ChiCTR2200057127</Chinese Clinical Trial Register></cross_references></HashMap>